Literature DB >> 19289153

Molecular mechanisms by which selenoproteins affect cancer risk and progression.

Pin Zhuo1, Alan M Diamond.   

Abstract

Selenoproteins comprise a unique class of proteins that contain selenium in the form of selenocysteine. Several selenoproteins have been implicated in the risk or development of cancers in humans by genetic data. These include Selenoprotein P, 3 members of the glutathione peroxidase family of anti-oxidant enzymes and Sep15. At-risk alleles in the germline indicate a likely role in determining susceptibility to cancer, while loss of heterozygosity or chromosomal epigenetic silencing indicate that the reduction in the levels of the corresponding proteins contribute to malignant progression. Lower levels of these proteins are likely to be detrimental due to the resulting cellular stress and perturbations in important regulatory signaling pathways. The genetic data indicating the involvement of these selenoproteins in cancer etiology are discussed, as are the possible mechanisms by which these genes might promote carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19289153      PMCID: PMC2763997          DOI: 10.1016/j.bbagen.2009.03.004

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  117 in total

1.  The effect of hOGG1 and glutathione peroxidase I genotypes and 3p chromosomal loss on 8-hydroxydeoxyguanosine levels in lung cancer.

Authors:  L J Hardie; J A Briggs; L A Davidson; J M Allan; R F King; G I Williams; C P Wild
Journal:  Carcinogenesis       Date:  2000-02       Impact factor: 4.944

2.  Manganese superoxide dismutase polymorphism, prediagnostic antioxidant status, and risk of clinical significant prostate cancer.

Authors:  Haojie Li; Philip W Kantoff; Edward Giovannucci; Michael F Leitzmann; J Michael Gaziano; Meir J Stampfer; Jing Ma
Journal:  Cancer Res       Date:  2005-03-15       Impact factor: 12.701

3.  Polymorphisms in the oxidative stress genes, superoxide dismutase, glutathione peroxidase and catalase and risk of non-Hodgkin's lymphoma.

Authors:  Tracy J Lightfoot; Christine F Skibola; Alex G Smith; Matthew S Forrest; Peter J Adamson; Gareth J Morgan; Paige M Bracci; Eve Roman; Martyn T Smith; Elizabeth A Holly
Journal:  Haematologica       Date:  2006-09       Impact factor: 9.941

4.  Suppression of the malignant phenotype in pancreatic cancer by overexpression of phospholipid hydroperoxide glutathione peroxidase.

Authors:  Jingru Liu; Juan Du; Yuping Zhang; Wenqing Sun; Brian J Smith; Larry W Oberley; Joseph J Cullen
Journal:  Hum Gene Ther       Date:  2006-01       Impact factor: 5.695

5.  Functional epigenomics identifies genes frequently silenced in prostate cancer.

Authors:  Dimitri Lodygin; Alexey Epanchintsev; Antje Menssen; Joachim Diebold; Heiko Hermeking
Journal:  Cancer Res       Date:  2005-05-15       Impact factor: 12.701

Review 6.  Glutathione peroxidases and redox-regulated transcription factors.

Authors:  Regina Brigelius-Flohé
Journal:  Biol Chem       Date:  2006 Oct-Nov       Impact factor: 3.915

7.  Association between the GCG polymorphism of the selenium dependent GPX1 gene and the risk of young onset prostate cancer.

Authors:  Z Kote-Jarai; F Durocher; S M Edwards; R Hamoudi; R A Jackson; A Ardern-Jones; A Murkin; D P Dearnaley; R Kirby; R Houlston; D F Easton; R Eeles
Journal:  Prostate Cancer Prostatic Dis       Date:  2002       Impact factor: 5.554

8.  Functional effects of a common single-nucleotide polymorphism (GPX4c718t) in the glutathione peroxidase 4 gene: interaction with sex.

Authors:  Catherine Méplan; Lynne K Crosley; Fergus Nicol; Graham W Horgan; John C Mathers; John R Arthur; John E Hesketh
Journal:  Am J Clin Nutr       Date:  2008-04       Impact factor: 7.045

Review 9.  Mechanisms of selenium chemoprevention and therapy in prostate cancer.

Authors:  Nagalakshmi Nadiminty; Allen C Gao
Journal:  Mol Nutr Food Res       Date:  2008-11       Impact factor: 5.914

10.  Loss of heterozygosity of the human cytosolic glutathione peroxidase I gene in lung cancer.

Authors:  J A Moscow; L Schmidt; D T Ingram; J Gnarra; B Johnson; K H Cowan
Journal:  Carcinogenesis       Date:  1994-12       Impact factor: 4.944

View more
  39 in total

1.  Functional and physical interaction between the selenium-binding protein 1 (SBP1) and the glutathione peroxidase 1 selenoprotein.

Authors:  Wenfeng Fang; Marci L Goldberg; Nicole M Pohl; Xiuli Bi; Chang Tong; Bin Xiong; Timothy J Koh; Alan M Diamond; Wancai Yang
Journal:  Carcinogenesis       Date:  2010-06-07       Impact factor: 4.944

2.  Inverse association between glutathione peroxidase activity and both selenium-binding protein 1 levels and Gleason score in human prostate tissue.

Authors:  Anita Jerome-Morais; Margaret E Wright; Rui Liu; Wancai Yang; Matthew I Jackson; Gerald F Combs; Alan M Diamond
Journal:  Prostate       Date:  2011-11-09       Impact factor: 4.104

3.  ROS signaling by NOX4 drives fibroblast-to-myofibroblast differentiation in the diseased prostatic stroma.

Authors:  Natalie Sampson; Rafal Koziel; Christoph Zenzmaier; Lukas Bubendorf; Eugen Plas; Pidder Jansen-Dürr; Peter Berger
Journal:  Mol Endocrinol       Date:  2011-01-27

Review 4.  Manganese superoxide dismutase and glutathione peroxidase-1 contribute to the rise and fall of mitochondrial reactive oxygen species which drive oncogenesis.

Authors:  Dede N Ekoue; Chenxia He; Alan M Diamond; Marcelo G Bonini
Journal:  Biochim Biophys Acta Bioenerg       Date:  2017-01-11       Impact factor: 3.991

5.  Loss of heterozygosity at the glutathione peroxidase 1 locus is not an early event in colon carcinogenesis.

Authors:  Marci Goldberg; David S Alberts; Julie A Buckmeier; Anil R Prasad; Robert S Krouse; Alan M Diamond
Journal:  Genes Cancer       Date:  2011-09

Review 6.  Molecular cross-talk between members of distinct families of selenium containing proteins.

Authors:  Emmanuel Ansong; Wancai Yang; Alan M Diamond
Journal:  Mol Nutr Food Res       Date:  2013-11-13       Impact factor: 5.914

7.  Natural allelic variations in glutathione peroxidase-1 affect its subcellular localization and function.

Authors:  Soumen Bera; Frank Weinberg; Dede N Ekoue; Kristine Ansenberger-Fricano; Mao Mao; Marcelo G Bonini; Alan M Diamond
Journal:  Cancer Res       Date:  2014-07-21       Impact factor: 12.701

8.  Contrasting roles of dietary selenium and selenoproteins in chemically induced hepatocarcinogenesis.

Authors:  Marina V Kasaikina; Anton A Turanov; Andrei Avanesov; Ulrich Schweizer; Sandra Seeher; Roderick T Bronson; Sergey N Novoselov; Bradley A Carlson; Dolph L Hatfield; Vadim N Gladyshev
Journal:  Carcinogenesis       Date:  2013-02-06       Impact factor: 4.944

Review 9.  Toward understanding success and failures in the use of selenium for cancer prevention.

Authors:  Holger Steinbrenner; Bodo Speckmann; Helmut Sies
Journal:  Antioxid Redox Signal       Date:  2013-03-21       Impact factor: 8.401

10.  Porcine serum can be biofortified with selenium to inhibit proliferation of three types of human cancer cells.

Authors:  Lv-Hui Sun; Jun-Gang Li; Hua Zhao; Jing Shi; Jia-Qiang Huang; Kang-Ning Wang; Xin-Jie Xia; Li Li; Xin Gen Lei
Journal:  J Nutr       Date:  2013-05-15       Impact factor: 4.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.